Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls-Reference-Cited by-同舟云学术

Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls

Published:2015-07 Issue:7 Volume:135 Page:1-5
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

van den Reek Juul M.P.A.,Kievit Wietske,Gniadecki Robert,Goeman Jelle J.,Zweegers Jeffrey,van de Kerkhof Peter C.M.,Seyger Marieke M.B.,de Jong Elke M.G.J.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference10 articles.

1. Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data;Aletaha;Arthritis Res Ther,2009

2. Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics;Aletaha;Curr Rheumatol Rep,2003

3. Survival probabilities (the Kaplan–Meier method);Bland;BMJ,1998

4. The comparative one-year performance of anti–tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study;Heiberg;Arthritis Rheum,2008

5. Understanding immortal time bias in observational cohort studies;Ho;Anaesthesia,2013

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis;JAMA Dermatology;2024-08-01

2. Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: single-center, retrospective study;Scientific Reports;2024-07-23

3. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation;JAMA Dermatology;2024-07-17

4. Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis;Journal of the American Academy of Dermatology;2024-07

5. Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis;Experimental Dermatology;2024-07